{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:56:48Z","timestamp":1777561008543,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010270","name":"Capital Health Research and Development of Special Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.thromres.2023.02.016","type":"journal-article","created":{"date-parts":[[2023,3,5]],"date-time":"2023-03-05T02:06:11Z","timestamp":1677981971000},"page":"33-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Low-dose immune tolerance induction therapy in severe hemophilia a children in China: Starting earlier resulted in better inhibitor eradication outcomes"],"prefix":"10.1016","volume":"225","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6290-9074","authenticated-orcid":false,"given":"Zhengping","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zekun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanru","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingzi","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Ai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7012-2420","authenticated-orcid":false,"given":"Man-Chiu","family":"Poon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4030-209X","authenticated-orcid":false,"given":"Runhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.thromres.2023.02.016_bb0005","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1056\/NEJMoa1516437","article-title":"A randomized trial of factor VIII and neutralizing antibodies in hemophilia A","volume":"374","author":"Peyvandi","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.thromres.2023.02.016_bb0010","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1182\/blood.2019000658","article-title":"Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A","volume":"134","author":"van den Berg","year":"2019","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.thromres.2023.02.016_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28474","article-title":"Outcomes in children with hemophilia A with inhibitors: results from a noninterventional study","volume":"67","author":"Oldenburg","year":"2020","journal-title":"Pediatr. Blood Cancer"},{"issue":"5","key":"10.1016\/j.thromres.2023.02.016_bb0020","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.transci.2019.08.008","article-title":"Hemophilia A with inhibitor: immune tolerance induction (ITI) in the mirror of time","volume":"58","author":"Nakar","year":"2019","journal-title":"Transfus. Apher. Sci."},{"issue":"Suppl 1","key":"10.1016\/j.thromres.2023.02.016_bb0025","first-page":"30","article-title":"Immune tolerance for the treatment of factor VIII inhibitors\u2013twenty years' 'Bonn protocol'","volume":"70","author":"Brackmann","year":"1996","journal-title":"Vox Sang."},{"issue":"3","key":"10.1016\/j.thromres.2023.02.016_bb0030","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1182\/blood.V86.3.983.983","article-title":"Low-dose immune tolerance induction in hemophilia a patients with inhibitors","volume":"86","author":"Mauser-Bunschoten","year":"1995","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2023.02.016_bb0035","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2516.1999.00195.x","article-title":"Tolerance induction using the Malm\u00f6 treatment model 1982\u20131995","volume":"5","author":"Freiburghaus","year":"1999","journal-title":"Haemophilia"},{"issue":"5","key":"10.1016\/j.thromres.2023.02.016_bb0040","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/hae.12730","article-title":"US guidelines for immune tolerance induction in patients with haemophilia A and inhibitors","volume":"21","author":"Valentino","year":"2015","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.thromres.2023.02.016_bb0045","first-page":"33","article-title":"Immune tolerance induction in haemophilia A patients with high-responding inhibitors to factor VIII: experience at a single institution","volume":"7","author":"Rocino","year":"2001","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.thromres.2023.02.016_bb0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-0037-1614414","article-title":"Immune tolerance therapy for haemophilia A patients with acquired factor VIII alloantibodies: comprehensive analysis of experience at a single institution","volume":"81","author":"Smith","year":"1999","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2023.02.016_bb0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00043426-199221000-00013","article-title":"Induction of immune tolerance in patients with hemophilia a and inhibitors","volume":"14","author":"Gruppo","year":"1992","journal-title":"Am. J. Pediatr. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.thromres.2023.02.016_bb0060","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/rth2.12248","article-title":"Low-dose immune tolerance induction for children with hemophilia a with poor-risk high-titer inhibitors: a pilot study in China","volume":"3","author":"Li","year":"2019","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2023.02.016_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12562","article-title":"Low-dose immune tolerance induction alone or with immunosuppressants according to prognostic risk factors in Chinese children with hemophilia a inhibitors","volume":"5","author":"Li","year":"2021","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2023.02.016_bb0070","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1182\/blood-2011-08-369132","article-title":"The principal results of the international immune tolerance study: a randomized dose comparison","volume":"119","author":"Hay","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2023.02.016_bb0075","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.blre.2018.02.003","article-title":"Review of immune tolerance induction in hemophilia A","volume":"32","author":"Schep","year":"2018","journal-title":"Blood Rev."},{"issue":"1","key":"10.1016\/j.thromres.2023.02.016_bb0080","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0037-1612943","article-title":"The North American Immune Tolerance Registry: practices, outcomes, outcome predictors","volume":"87","author":"DiMichele","year":"2002","journal-title":"Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.thromres.2023.02.016_bb0085","first-page":"1186","article-title":"Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success","volume":"86","author":"Mariani","year":"2001","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.thromres.2023.02.016_bb0090","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/hae.12608","article-title":"Prompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia A complicated by inhibitors: experience of two U.S. centres","volume":"21","author":"Nakar","year":"2015","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.thromres.2023.02.016_bb0095","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2516.2007.01621.x","article-title":"Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors","volume":"14","author":"Unuvar","year":"2008","journal-title":"Haemophilia"},{"issue":"Suppl 1","key":"10.1016\/j.thromres.2023.02.016_bb0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1423-0410.1999.tb00011.x","article-title":"Comparison of the international immune tolerance registry and the North American immune tolerance registry","volume":"77","author":"Kroner","year":"1999","journal-title":"Vox Sang."},{"issue":"3","key":"10.1016\/j.thromres.2023.02.016_bb0105","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/hae.12102","article-title":"Immune tolerance induction in haemophilia A patients with inhibitors by treatment with recombinant factor VIII: a retrospective non-interventional study","volume":"19","author":"Rivard","year":"2013","journal-title":"Haemophilia"},{"issue":"10 Suppl","key":"10.1016\/j.thromres.2023.02.016_bb0110","first-page":"45","article-title":"The German Registry of immune tolerance treatment in hemophilia\u20131999 update","volume":"85","author":"Lenk","year":"2000","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.thromres.2023.02.016_bb0115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1055\/s-0038-1653759","article-title":"The Nijmegen modification of the Bethesda assay for factor VIII: C inhibitors: improved specificity and reliability","volume":"73","author":"Verbruggen","year":"1995","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2023.02.016_bb0120","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2516.2009.02191.x","article-title":"Limited blood sampling for pharmacokinetic dose tailoring of FVIII in the prophylactic treatment of haemophilia A","volume":"16","author":"Bj\u00f6rkman","year":"2010","journal-title":"Haemophilia"},{"issue":"5","key":"10.1016\/j.thromres.2023.02.016_bb0125","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jaip.2014.06.003","article-title":"Rituximab and immune deficiency: case series and review of the literature","volume":"2","author":"Kaplan","year":"2014","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"7","key":"10.1016\/j.thromres.2023.02.016_bb0130","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.4169","article-title":"Association of immunoglobulin levels, infectious risk, and mortality with rituximab and hypogammaglobulinemia","volume":"1","author":"Barmettler","year":"2018","journal-title":"JAMA Netw. Open"},{"issue":"6","key":"10.1016\/j.thromres.2023.02.016_bb0135","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/hae.14381","article-title":"Immune tolerance induction in severe haemophilia A: a UKHCDO inhibitor and paediatric working party consensus update","volume":"27","author":"Hart","year":"2021","journal-title":"Haemophilia"},{"issue":"Suppl 3","key":"10.1016\/j.thromres.2023.02.016_bb0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/hae.13445","article-title":"Immune tolerance induction: what have we learned over time?","volume":"24","author":"Brackmann","year":"2018","journal-title":"Haemophilia"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823000658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823000658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:49:48Z","timestamp":1758736188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384823000658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":28,"alternative-id":["S0049384823000658"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.02.016","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-dose immune tolerance induction therapy in severe hemophilia a children in China: Starting earlier resulted in better inhibitor eradication outcomes","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}